9 results
PRE 14A
HLVX
HilleVax Inc
12 Apr 24
Preliminary proxy
4:05pm
and Chief Patient Officer at Merck & Co., Inc., where she was responsible for patient engagement, corporate social responsibility, ESG, and other functions
DEF 14A
HLVX
HilleVax Inc
28 Apr 23
Definitive proxy
4:32pm
social responsibility, ESG, and other functions. Formerly, Dr. Gerberding oversaw the communications and global public policy functions. She joined … . Gerberding served as Executive Vice President and Chief Patient Officer at Merck & Co., Inc., where she is responsible for patient engagement, corporate
424B4
HLVX
HilleVax Inc
29 Apr 22
Prospectus supplement with pricing info
4:02pm
social responsibility, ESG, and other functions. Formerly, Dr. Gerberding oversaw the communications and global public policy functions. She joined Merck … has served as Executive Vice President and Chief Patient Officer at Merck & Co.,
Inc., where she is responsible for patient engagement, corporate
S-1/A
1os7s4 fwfr
18 Apr 22
IPO registration (amended)
6:08am
S-1
k91t3b6d
6 Apr 22
IPO registration
4:21pm
DRS/A
zpjh1g pktb
23 Nov 21
Draft registration statement (amended)
12:00am
DRS
9az05z4jen wzvr5
19 Oct 21
Draft registration statement
12:00am
- Prev
- 1
- Next